Blinding in Clinical Trials
2. Why Do We Blind?
Blinding is used to prevent conscious or unconscious bias in the design of a clinical trial and how it is carried out. This is important because bias can affect recruitment and allocation, care, attitudes, assessments, etc.
It is used to ensure the objectivity of participants, study staff, clinicians, data collectors, outcome adjudicators and data analysts.